Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights

June 1, 2026 UCBN News, Syndication Comments Off on Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights

BOULDER, Colo.–(BUSINESS WIRE)– #ArcherAnalysis–IDT’s library prep solutions join Illumina’s extensive software ecosystem to enable streamlined analysis for IDT’s FFPE and cfDNA workflows.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

News

Presidential Executive Order Validates DeFloria’s Strategy in Pharmaceutical Cannabinoid Drug Development

December 19, 2025 UCBN News, Syndication Comments Off on Presidential Executive Order Validates DeFloria’s Strategy in Pharmaceutical Cannabinoid Drug Development

DeFloria Advancing Charlotte’s Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug LOUISVILLE, Colo. and WASHINGTON, Dec. 19, 2025 /PRNewswire/ – DeFloria Inc., a botanical drug development Company […]

No Picture
News

Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

May 23, 2022 UCBN News Comments Off on Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced today the Seattle Children’s activation of the Phase 1 ENLIGHTen clinical trial in […]